Contacts

The role of the Investor Relations Department is to maintain a transparent and comprehensive dialogue with the financial community about Sanofi's strategy, outlook and financial data, its economic environment and any other useful information.

For general inquiries
Please contact the switchboard, +33 (0)1 53 77 40 00

To contact the Investors Relations team
Mail: investor.relations@sanofi.com

Thomas Kudsk Larsen

Head of Investor Relations


Global
 +44 7545 513 693

Nathalie Pham

Investor Relations Officer
Vaccines, Opella, Rare diseases

Europe
+33 7 85 93 30 17

Alizé Kaisserian

Investor Relations Manager
Neurology, Oncology, all pipeline

Europe
+33 6 47 04 12 11

Marie Lang

Investor Relations Manager
Corporate access

Europe
+33 6 70 83 59 31

Thibaud Chatelet

Investor Relations Manager
Finance, ESG

Europe
+33 6 80 80 89 90

Aline Communeau

Investor Relations Coordinator
Private shareholders

Europe
+33 6 98 90 45 15

Felix Lauscher

Head of Investor Relations
General medicines

North America & Asia
+1 908 612 7239

Tarik Elgoutni

Investor Relations Officer
Immunology

North America
+1 617 528 8427

Keita Browne

Investor Relations Officer
Rare diseases, finance

North America 
+1 617 685 6662

Caroline Kuriata

Investor Relations Analyst
Corporate access, US

North America
+1 908 981 6401

North America and Asia Europe
SanofiUS Investor Relations55 Corporate DrivePO Box 5925Bridgewater, NJ 08807USA
SanofiInvestor Relations46 avenue de la Grande Armée75017 ParisFRANCE